Healthcare


 Austco Healthcare's Impressive Growth Journey

Austco Healthcare's Impressive Growth Journey

March 22, 2025 05:30 PM AEDT| By Team Kalkine Media

Highlights,Austco Healthcare's share price soared 455% over five years.,The company achieved a total shareholder return of 478% over the same period.,Recent insider buying suggests potential confidence in future growth.,Investors have often been on t...

 Trajan Group's Innovative Ventures and Global Strategy

Trajan Group's Innovative Ventures and Global Strategy

March 22, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Trajan Group's micro blood sampling tools are influencing both terrestrial and space applications, providing precise samples in even the most remote locations.,The company is at the forefront of detecting 'forever chemicals' and impurities...

 Institutional Influence and Ownership Structure of Cochlear Limited (COH)

Institutional Influence and Ownership Structure of Cochlear Limited (COH)

March 21, 2025 07:30 PM AEDT| By Team Kalkine Media

Institutional Influence and Ownership Structure of Cochlear Limited (COH)

 Compumedics Secures $20M in Chinese MEG Sales as Demand for Brain Imaging Tech Rises

Compumedics Secures $20M in Chinese MEG Sales as Demand for Brain Imaging Tech Rises

March 21, 2025 06:57 PM AEDT| By Team Kalkine Media

Highlights,$20M in MEG system sales achieved in China,Latest $5.7M deal signed with Hangzhou Normal University,Growing momentum signals strong future potential in global neuroimaging market,Compumedics (ASX:CMP), a leading developer of brain research...

 Nanosonics Shares Surge After US Approval, But Analysts Urge Caution on Valuation

Nanosonics Shares Surge After US Approval, But Analysts Urge Caution on Valuation

March 21, 2025 04:42 PM AEDT| By Team Kalkine Media

Highlights,Nanosonics shares jump after US FDA greenlight,CORIS tool sees early investor excitement,Analysts flag slow rollout and valuation concerns,Nanosonics (ASX:NAN) saw a strong rally in its share price following the US Food and Drug Administra...

 Can Cochlear (ASX:COH) Regain Momentum in 2025? Here’s What the Numbers Say

Can Cochlear (ASX:COH) Regain Momentum in 2025? Here’s What the Numbers Say

March 21, 2025 02:42 PM AEDT| By Team Kalkine Media

Highlights,Revenue growth averaging 14.3% per year over 3 years,Strong gross margin of 74.9% and healthy net profit,Low debt levels and solid return on equity,The share price of Cochlear (ASX:COH), a global leader in hearing solutions, has declined b...

 MedAdvisor Limited's (ASX:MDR) Stock Performance: A Deep Dive

MedAdvisor Limited's (ASX:MDR) Stock Performance: A Deep Dive

March 21, 2025 01:30 PM AEDT| By Team Kalkine Media

Highlights,MedAdvisor Limited (ASX:MDR) has seen a significant stock price drop.,The company’s growth forecasts are lagging behind the industry.,Revenue trends show a mixed performance over recent years.,MedAdvisor Limited (ASX:MDR) has experienced a...

 ResMed (ASX:RMD) A Closer Look at Its Market Performance and Growth Potential

ResMed (ASX:RMD) A Closer Look at Its Market Performance and Growth Potential

March 21, 2025 12:07 PM AEDT| By Team Kalkine Media

Highlights,ResMed’s Market Movement,: Shares of ResMed (RMD) have declined by 4.6% since the start of 2025.,Healthcare Industry Resilience,: The sector is known for its stable revenue streams and growth potential.,Valuation Insights,: Current price-t...

 FDA Greenlights Telix’s Advanced Prostate Cancer Imaging Agent, Gozellix®

FDA Greenlights Telix’s Advanced Prostate Cancer Imaging Agent, Gozellix®

March 21, 2025 12:05 PM AEDT| By Team Kalkine Media

Highlights,FDA approves,Telix’s,next-gen prostate cancer imaging agent,Gozellix,® offers wider access through extended shelf life,Reimbursement eligibility improves patient reach,Telix Pharmaceuticals Limited (ASX:TLX) has achieved a major regulatory...

 Reviving Potential: How Race Oncology’s Breakthrough Could Redefine Cancer Treatment

Reviving Potential: How Race Oncology’s Breakthrough Could Redefine Cancer Treatment

March 21, 2025 11:37 AM AEDT| By Team Kalkine Media

Highlights,Race Oncology brings back a shelved cancer drug with modern innovation,New formulation offers 20 years of exclusive patent protection,Potential heart-protective benefits in combination chemotherapy,Race Oncology (ASX:RAC) is turning heads...

 Anteris Technologies' DurAVR® Transcatheter Valve Shows Strong One-Year Performance, Paving the Way for Next Steps

Anteris Technologies' DurAVR® Transcatheter Valve Shows Strong One-Year Performance, Paving the Way for Next Steps

March 21, 2025 11:29 AM AEDT| By Team Kalkine Media

Highlights,DurAVR,® THV continues to,demonstrate,exceptional durability and hemodynamic performance.,No cases of prosthesis-patient mismatch (PPM) were,observed,, a key factor in valve success.,The findings will support,Anteris,Technologies' (AVR) up...

 ASX Healthcare Stocks on the Rise: Innovations and Industry Developments

ASX Healthcare Stocks on the Rise: Innovations and Industry Developments

March 21, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlight,The ASX healthcare sector records growth, shaken off global concerns.,Nanosonics receives FDA De Novo clearance for an endoscope cleaning system.,EMVision's portable First Responder device shows promise in stroke detection.,The ASX healthca...

 Understanding the Dynamics Behind Immutep Limited's (ASX:IMM) Shareholding

Understanding the Dynamics Behind Immutep Limited's (ASX:IMM) Shareholding

March 20, 2025 01:32 PM AEDT| By Team Kalkine Media

Highlights,Institutional investors hold the majority shares in Immutep Limited (IMM).,The top seven investors control over 50% of the company's stock.,Analysts' perspectives and shareholder data provide insights into the company's future.,A comprehen...

 Is Red Metal (ASX:RDM) Making Wise Decisions with Its Cash?

Is Red Metal (ASX:RDM) Making Wise Decisions with Its Cash?

March 20, 2025 01:31 PM AEDT| By Team Kalkine Media

Highlights,Red Metal shows a 14-month cash runway as of December 2024.,Cash burn reduced by 6% year over year.,Future cash raises may lead to shareholder dilution.,Shareholders of Red Metal (ASX:RDM) may notice the company's cash dynamics intriguing,...

 Rhythm Biosciences (ASX:RHY) Celebrates Milestone with Initial Commercial Sales of geneType Products

Rhythm Biosciences (ASX:RHY) Celebrates Milestone with Initial Commercial Sales of geneType Products

March 20, 2025 12:56 PM AEDT| By Team Kalkine Media

Highlights,First commercial sales recorded for,geneType,products.,Strategic growth targeted in enterprise and global markets.,Anticipation builds for upcoming,ColoSTAT,® revenue streams.,Rhythm Biosciences Ltd (ASX:RHY) has achieved a significant mil...

 Market Cautious on Doctor Care Anywhere Group (ASX:DOC) Despite Low Price-to-Sales Ratio

Market Cautious on Doctor Care Anywhere Group (ASX:DOC) Despite Low Price-to-Sales Ratio

March 20, 2025 12:52 PM AEDT| By Team Kalkine Media

Highlights,Doctor Care Anywhere Group sports a notably low P/S ratio.,Recent revenue trends fall short compared to industry growth.,Future revenue projections,remain,conservative against the industry.,Doctor Care Anywhere Group PLC (ASX:DOC) presents...

 Optimism in the Australian Healthcare Sector: Analysts Highlight CSL and ResMed

Optimism in the Australian Healthcare Sector: Analysts Highlight CSL and ResMed

March 20, 2025 11:43 AM AEDT| By Team Kalkine Media

Highlights,Positive outlook for CSL (CSL) and ResMed (RMD).,Balanced prospects for other healthcare stocks.,Caution,advised,for Ramsay Health Care and Cochlear.,The Australian healthcare sector is receiving a fresh wave of attention from analysts, wi...

 We Don't Have Major Concerns Regarding LTR Pharma's (LTP) Cash Burn Rate

We Don't Have Major Concerns Regarding LTR Pharma's (LTP) Cash Burn Rate

March 19, 2025 03:34 PM AEDT| By Team Kalkine Media

Highlights:,LTR Pharma maintains a strong cash position with no outstanding debt.,Recent cash burn increase attributed to operational expansion.,Future funding options include capital raising through share issuance.,The pharmaceutical sector continue...

 Imricor Medical Systems (ASX:IMR) Trading Halted Ahead of Capital Raising Announcement

Imricor Medical Systems (ASX:IMR) Trading Halted Ahead of Capital Raising Announcement

March 19, 2025 11:40 AM AEDT| By Team Kalkine Media

Highlights,Imricor,(IMR) shares suspended ahead of capital raising announcement.,Trading halt in effect until company provides details.,Imricor,plans significant financial move for future growth.,Imricor Medical Systems Ltd (ASX:IMR) has seen its sha...

 Emvision's Remote Stroke Detection Breakthrough and Biotech Sector Developments

Emvision's Remote Stroke Detection Breakthrough and Biotech Sector Developments

March 19, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Emvision Medical Devices (EMV) initiates trial for innovative remote stroke detection technology.,Despite challenging market conditions, several biotechs, including Imricor (IMR), successfully raise equity.,Imugene (IMU) secures FDA fast t...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.